WISeKey International Holding Ltd ADR Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
1analyst covering
FY Revenue (est.)
$25.3Mnext fiscal year
Monitoring Framework
Key Performance Indicators
Consolidated Revenue Growth Annually62.0%Target: 50% to 100% growth for FY 2026
SEALSQ Commercial Pipeline Quarterly200MTarget: Commercial acceleration and conversion of pipeline from 2026 through 2029
Cash and Short-Term Investments Quarterly535MTarget: Strategic deployment in post-quantum R&D, manufacturing scale-up, and acquisitions
Watch Items
- Commercialization of QS7001 Post-Quantum ChipTrigger: First production revenues expected in late 2026Action: Monitor government contract wins and delivery timelines for the newly certified EAL5+ chip.
- Redomiciliation to the British Virgin IslandsTrigger: Effectiveness of Form F-4 registration statementAction: Track shareholder approval and regulatory clearance for the proposed corporate restructuring.
- Consolidated Net LossesTrigger: Net loss of $38.2 million in FY 2025Action: Evaluate operating expense trends and the timeline to profitability as R&D investments transition to commercial scale.
Research as of 24 Jul 2026